Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Acutus Medical Inc (AFIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2019	12-2018	12-2017	12-2006
Cash Flows From Operating Activities
Net Income	-97,039	-47,907	N/A	N/A
Depreciation Amortization	20,593	5,338	N/A	N/A
Accounts receivable	-96	26	N/A	N/A
Accounts payable and accrued liabilities	2,111	18	N/A	N/A
Other Working Capital	-2,186	1,496	N/A	N/A
Other Operating Activity	20,631	7,249	0	0
Operating Cash Flow	$-55,986	$-33,780	$N/A	$N/A

Cash Flows From Investing Activities
PPE Investments	-3,395	-2,038	N/A	N/A
Net Acquisitions	-3,000	N/A	N/A	N/A
Purchase Of Investment	-68,735	-14,304	N/A	N/A
Sale Of Investment	14,700	11,600	N/A	N/A
Purchase Sale Intangibles	-10,000	N/A	N/A	N/A
Other Investing Activity	-10,000	0	0	0
Investing Cash Flow	$-70,430	$-4,742	$N/A	$N/A

Cash Flows From Financing Activities
Debt Issued	77,000	37,815	N/A	N/A
Debt Repayment	-15,000	-600	N/A	N/A
Common Stock Issued	108	348	N/A	N/A
Other Financing Activity	64,231	-149	0	0
Financing Cash Flow	$126,339	$37,414	$N/A	$N/A

Exchange Rate Effect	-96	-43	N/A	N/A
Beginning Cash Position	9,775	10,926	N/A	N/A
End Cash Position	9,602	9,775	N/A	N/A
Net Cash Flow	$-173	$-1,151	$N/A	$N/A

Free Cash Flow
Operating Cash Flow	-55,986	-33,780	N/A	N/A
Capital Expenditure	-3,395	-2,038	N/A	N/A
Free Cash Flow	-59,381	-35,818	0	0